Disseminated Neuroblastoma Unknown Status Phase 1 / 2 Trials for Aldesleukin (DB00041)

Back to Disseminated Neuroblastoma

Also known as: Disseminated Neuroblastoma (NB)

IndicationStatusPhase
DBCOND0029099 (Disseminated Neuroblastoma)Unknown Status1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02173093Activated T Cells Armed With GD2 Bispecific Antibody in Children and Young Adults With Neuroblastoma and OsteosarcomaTreatment